MtoZ Biolabs - Model de-novo-sequencing -De Novo Sequencing

Accurate determination of protein sequences is fundamental in the development of commercial monoclonal antibodies, vaccines, and diagnostic kits. Traditional sequencing methods uses database searching for protein sequencing, and has limitations for sequencing the unknown proteins, which may not be included in the database. De novo sequencing is a novel sequencing methods, with no need for database searching, and therefore, is the optimal method for analyzing unknown proteins and antibodies. Based on the world's most advanced mass spectrometry instrument, Obitrap Fusion Lumos, and combined with rich experience in bioinformatics analysis, MtoZ Biolabs has established a whole new generation of de novo sequencing platform that can achieve accurate sequence analysis of monoclonal antibodies and proteins, independent of any database searching. The primary sequence of proteins and antibodies and any mutations on the sequence can be analyzed quickly and accurately, without any prior information of the protein.

1. Advanced High-Resolution Mass Spectrometry Technology
2. 100% Protein/Antibody Sequence Coverage
3. 95% Accuracy for Sequencing the First Amino Acid
4. Minimum Amount of Sample Required

Antibody De Novo Sequencing

MtoZ Biolabs is proud to offer antibody de novo sequencing service, using high-resolution Obitrap Fusion Lumos mass spectrometry.

Protein De Novo Sequencing

MtoZ Biolabs develops an advanced mass spectrometry platform and ensures high-efficient and accurate protein de novo sequence analysis.

Protein Sequencing

Protein De Novo Seq

N-Terminal Sequencing

C-Terminal Sequencing

Edman Degradation

Protein Full-Length Sequencing

Protein Analysis

Protein Identification

Protein Mass Measurement

LC-MS Analysis of Pull-Down Proteins

Native MS Analysis

PTM Analysis

Phospho Proteomics

Acetyl Proteomics

Ubiquitin Proteomics

Glyco Proteomics

Disulfide Bond

Histone Modifications

MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The name of MtoZ represents “mass to charge ratio” in mass spectrometry analysis, as most of our services are provided based on our well-established mass spectrometry platforms. Our services allow for the rapid and efficient development of research projects, including protein analysis, proteomics, and metabolomics programs.

MtoZ Biolabs is specialized in quantitative multiplexed proteomics and metabolomics applications through the establishment of state-of-the-art mass spectrometry platforms, coupled with high-performance liquid chromatography technology. We are committed to developing efficient, and effective tools for addressing core bioinformatics problems. With a continuing focus on quality, MtoZ Biolabs is well equipped to help you with your needs in proteomics, metabolomics, bioinformatics, and biopharmaceutical research. Our ultimate aim is to provide more rapid, high-throughput, and cost-effective analysis, with exceptional data quality and minimal sample.

Email: [email protected]